Amnavero.
← Research directory

Research profile

BPC-157

BPC-157 has been studied in animal models of tissue injury and inflammation. Ulcerative colitis was among the proposed uses reviewed by FDA staff.

  • Predominantly preclinical evidence
  • Evaluation only
Amnavero BPC-157 research vial concept packaging
Amnavero BPC-157
Concept packaging

What the research found

FDA’s review did not identify studies in people with ulcerative colitis using the proposed oral, subcutaneous, nasal, or transdermal routes.

What remains uncertain

Animal findings leave open whether BPC-157 helps people heal, and the limited human evidence leaves important safety questions.